cdmo.directory
← Compare landing

Cell Therapies vs Hillgene

Side-by-side profile data from each company listing. Missing fields stay blank rather than filled with assumptions.

CategoryCell TherapiesHillgene
SummaryGMP contract manufacturer of autologous and allogeneic cell therapies from first-in-human trials through commercial supply, with two decades of experience in CAR-T, mesenchymal stromal cells, TILs, and pluripotent stem cell derivatives. Offers end-to-end cold chain management, process development, quality control analytics, and regulatory consulting across Australia and Asia-Pacific.Hillgene is a leading CDMO provider specializing in cell therapy manufacturing, offering end-to-end solutions for CAR-T, TCR-T, CAR-NK, and UCAR-T cell therapies with GMP facilities in Suzhou and Belgium.
Services
  • Cell Therapy Manufacturing
  • Autologous Cell Therapy Manufacturing
  • Allogeneic Cell Therapy Manufacturing
  • Process Development
  • Technology Transfer
  • CMC Analytical Development
  • Quality Control Testing
  • Cold-Chain Storage & Logistics
  • CMC Regulatory Submission Support
  • Regulatory Affairs
  • Lentiviral Vector Manufacturing
  • Cell Therapy Manufacturing
  • Autologous Cell Therapy Manufacturing
  • Allogeneic Cell Therapy Manufacturing
  • mRNA Manufacturing
  • Quality Control Testing
  • CMC Regulatory Submission Support
Modalities
  • Cell Therapy
  • Gene Therapy
  • mRNA
  • Cell Therapy
  • Gene Therapy
Development capabilities
  • Analytical method development
  • ICH stability testing
  • Analytical method development
  • Formulation development
  • Cell line development
Manufacturing capabilities
  • Drug Substance (DS)
  • Drug Product (DP)
  • Drug Substance (DS)
  • Drug Product (DP)
  • Expression: Mammalian
  • Expression: Cell-Free
  • Single-Use / Disposable
Locations
  • Headquarters / Manufacturing & Development, Melbourne, Victoria, Australia
  • Headquarters, Suzhou, Jiangsu, China
  • R&D Center, Suzhou, Jiangsu, China
  • GMP Facility, Belgium, Belgium
Certifications
  • TGA · Identifier: TGA-licensed
  • FDA · Identifier: FDA inspection-ready
  • PMDA · Identifier: PMDA inspection-ready
  • EMA · Identifier: EMA inspection-ready
  • FDA · Identifier: DMF filing approval for genetically modified K562 feeder cells

Find similar companies

Cell Therapies alternatives · Hillgene alternatives

Markdown mirror: /compare/celltherapies/hillgene.md